Stay updated with breaking news from Technology Expected To. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
New Zinc Nanoparticle Technology Replaces the Lipid Nanoparticle Technology Employed in Current mRNA COVID-19 Vaccines ZNP Technology Expected to Improve mRNA Vaccine Temperature Stability for... | January 4, 2022
New Zinc Nanoparticle (ZNP) Technology Replaces the Lipid Nanoparticle (LNP) Technology Employed in Current mRNA COVID-19 Vaccines ZNP Technology Expected...